Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis of a multicenter, open-label randomized trial - Suzuki, Manabu; Matsunaga, Akihiro; Miyoshi-Akiyama, Tohru; Terada-Hirashima, Junko; Sadamasu, Kenji; Nagashima, Mami; Takasaki, Jin; Izumi, Shinyu; Hojo, Masayuki; Ishizaka, Yukihito; Sugiyama, Haruhito (Drug Discoveries & Therapeutics, 2023)
Keywords: anti-viral effect; asymptomatic or mild COVID-19; randomized clinical trial; SARS-CoV-2 nucleocapsid protein antibody; viral load